MDT vs. BMY
Compare and contrast key facts about Medtronic plc (MDT) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MDT or BMY.
Correlation
The correlation between MDT and BMY is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
MDT vs. BMY - Performance Comparison
Loading data...
Key characteristics
MDT:
0.15
BMY:
0.11
MDT:
0.46
BMY:
0.38
MDT:
1.06
BMY:
1.05
MDT:
0.14
BMY:
0.06
MDT:
0.80
BMY:
0.35
MDT:
6.46%
BMY:
8.46%
MDT:
21.64%
BMY:
31.25%
MDT:
-57.63%
BMY:
-70.62%
MDT:
-29.98%
BMY:
-39.53%
Fundamentals
MDT:
$109.16B
BMY:
$94.81B
MDT:
$3.28
BMY:
$2.54
MDT:
25.95
BMY:
17.37
MDT:
1.46
BMY:
2.26
MDT:
3.29
BMY:
1.99
MDT:
2.21
BMY:
5.45
MDT:
$24.61B
BMY:
$47.64B
MDT:
$15.68B
BMY:
$31.43B
MDT:
$6.89B
BMY:
$16.18B
Returns By Period
In the year-to-date period, MDT achieves a 6.31% return, which is significantly higher than BMY's -20.28% return. Over the past 10 years, MDT has outperformed BMY with an annualized return of 3.56%, while BMY has yielded a comparatively lower -1.06% annualized return.
MDT
6.31%
0.04%
-2.63%
3.32%
0.71%
3.56%
BMY
-20.28%
-14.06%
-22.80%
3.53%
-3.75%
-1.06%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MDT vs. BMY — Risk-Adjusted Performance Rank
MDT
BMY
MDT vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Medtronic plc (MDT) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
MDT vs. BMY - Dividend Comparison
MDT's dividend yield for the trailing twelve months is around 3.32%, less than BMY's 5.53% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDT Medtronic plc | 3.32% | 3.49% | 3.34% | 3.44% | 2.39% | 1.95% | 1.87% | 2.15% | 2.24% | 2.34% | 1.88% | 1.66% |
BMY Bristol-Myers Squibb Company | 5.53% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
MDT vs. BMY - Drawdown Comparison
The maximum MDT drawdown since its inception was -57.63%, smaller than the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for MDT and BMY. For additional features, visit the drawdowns tool.
Loading data...
Volatility
MDT vs. BMY - Volatility Comparison
The current volatility for Medtronic plc (MDT) is 5.66%, while Bristol-Myers Squibb Company (BMY) has a volatility of 10.67%. This indicates that MDT experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
MDT vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Medtronic plc and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MDT vs. BMY - Profitability Comparison
MDT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Medtronic plc reported a gross profit of 5.51B and revenue of 8.29B. Therefore, the gross margin over that period was 66.5%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported a gross profit of 8.17B and revenue of 11.20B. Therefore, the gross margin over that period was 72.9%.
MDT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Medtronic plc reported an operating income of 1.65B and revenue of 8.29B, resulting in an operating margin of 19.9%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported an operating income of 3.52B and revenue of 11.20B, resulting in an operating margin of 31.4%.
MDT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Medtronic plc reported a net income of 1.29B and revenue of 8.29B, resulting in a net margin of 15.6%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported a net income of 2.46B and revenue of 11.20B, resulting in a net margin of 21.9%.